Results 251 to 260 of about 230,940 (319)

tsJT16, a Cell Cycle ts Mutant of Rat Fibroblast Defective in Early GO/G1 Transition, Fails to Induce G1-cyclin and cdk2 Genes after Serum Stimulation at the Nonpermissive Temperature.

, 1994
Tomonori Ueohzono, Emiko Tanida-Miyake, Nobuhiro Kato, Toshinori Ide   +3 more
openalex   +2 more sources

Engineered Exosome‐Based Senolytic Therapy Alleviates Stroke by Targeting p21+CD86+ Microglia

Exploration, EarlyView.
We identified a harmful immune cell type, p21+CD86+ microglia, driving post‐stroke inflammation and developed a targeted exosome‐based therapy (Que@micro‐Exo) to eliminate these cells. This innovative treatment reduced inflammation, alleviated brain damage, and improved recovery in stroke models, offering a promising strategy for stroke and other ...
Jialei Yang, Shipo Wu, Miao He
wiley   +1 more source

CDK4/6 inhibitors upregulate cIAP1/2, and Smac mimetic LCL161 enhances their antitumor effects in cholangiocarcinoma cells. [PDF]

Sci Rep
Menapree P, Duangthim N, Sae-Fung A, Sonkaew S, Jitkaew S.   +4 more
europepmc   +1 more source

Radiation induced degradation of cyclin a and its relationship to g1 arrest in a human malignant glioma line

, 1994
Patrick W. McLaughlin, Mohan Chelladurai, Tahnee Hartman, Dave Boothman, Steven Ethier   +4 more
openalex   +1 more source

The discovery of cyclin (II)

Cell, 2004
openaire   +2 more sources

Delivery of Natural Small Molecules Through Nanocarriers for Cancer Treatment

Food Frontiers, EarlyView.
Natural small molecules through nanocarriers for cancer treatment ABSTRACT Cancer is a formidable adversary, accounting for the second highest number of fatalities worldwide. A multitude of studies have indicated that naturally sourced small‐molecule compounds, owing to their low toxicity and multi‐target capabilities, significantly aid in the fight ...
Fangting Ye, Shaojie Zheng, Shuo Shan, Jiaer Cai, Yufan Liu, Weichao Chen, Xinxin He, Chao Zhao   +7 more
wiley   +1 more source

Trastuzumab Decreases the Expression of G1/S Regulators and Syndecan-4 Proteoglycan in Human Rhabdomyosarcoma. [PDF]

Int J Mol Sci
Szabo DJ, Toth E, Szabo K, Hegedus ZK, Bozsity-Farago N, Zupko I, Rovo L, Xiao X, Xu L, Keller-Pinter A.   +9 more
europepmc   +1 more source

Harnessing Jasminum Bioactive Compounds: Updated Insights for Therapeutic and Food Preservation Innovations

Food Frontiers, EarlyView.
Jasminum bioactives improve food preservation by providing antimicrobial and antioxidant effects, especially when incorporated into active packaging, edible films, and nanoformulations that enhance stability and controlled release. They also offer many pharmacological benefits, including anti‐inflammatory, neuroprotective, and wound‐healing properties.
Antonio Rescigno, Paolo Zucca, Stefania Peddio, Sriranjani Srikanth, Niharika Prakash Kaushik, Nanjangud Venkatesh Anil Kumar, Gerardo Leyva‐Gómez, Dorota Kregiel, Ibrahim M. Abu‐Reidah, Surjit Sen, Krishnendu Acharya, William N. Setzer, Marta Palma‐Morales, Miquel Martorell, Daniela Calina, Celia Rodríguez‐Pérez, Javad Sharifi‐Rad, William C. Cho   +17 more
wiley   +1 more source

Advances in CDK4 and 6 Inhibitors: Transforming Breast Cancer Treatment. [PDF]

Cancers (Basel)
Santander Ballestín S, Abadía Labena M, Avedillo-Salas A, Marco Continente C, Arribas Blázquez M, Luesma Bartolomé MJ.   +5 more
europepmc   +1 more source

Two Arabidopsis cyclin promoters mediate distinctive transcriptional oscillation in synchronized tobacco BY-2 cells.

, 1996
Orit Shaul, Vladimir Mironov, Sylvia Burssens, M. Van Montagu, Dirk Inzé   +4 more
openalex   +1 more source